Method for producing krait antibacterial peptide by using recombinant pichia pastoris
By optimizing the fermentation medium in recombinant Pichia pastoris and using methanol induction, the high cost and complex purification problems of the antimicrobial peptide cathelicin-BF from the golden ring snake were solved, enabling efficient, large-scale production and low-cost expression of the antimicrobial peptide.
Patent Information
- Application Number
- CN202411246743.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-06
- Publication Date
- 2024-11-29
AI Technical Summary
The acquisition and purification process of cathelicin-BF, an antimicrobial peptide from the golden ring snake, is complex and costly, which cannot meet the requirements for large-scale production and widespread application. The selection and optimization of expression systems for recombinant DNA technology still present challenges.
A method for producing antimicrobial peptides from *Pichia pastoris* using recombinant *Pichia pastoris* was developed. By optimizing the fermentation medium and adding bioregulators such as glutamine and cholesterol, combined with methanol induction, efficient expression and simplified purification processes were achieved, reducing production costs.
Large-scale production of cathelicin-BF, an antimicrobial peptide from the golden ring snake, has been achieved, increasing protein yield by more than 17%, achieving high purity, simplifying subsequent purification processes, and reducing production costs.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biological fermentation. Background Art
[0002] Snake venom peptides are a class of small molecule proteins or polypeptides extracted from snake venom. These peptides play an important role in snake venom and exert their effects through a variety of mechanisms, including interfering with neurotransmission, destroying blood coagulation mechanisms, dissolving cell membranes, etc. Because of their high biological activity, they can produce significant physiological effects even at low concentrations, and can quickly bind to their targets and exert their effects, making them have broad application prospects in the fields of medical research, drug development, and medical cosmetics.
[0003] Bungarus belongs to the genus Bungarus of the family Elapidae. A variety of active ingredients have been found in Bungarus venom. Bungarus cathelicin-BF is an antimicrobial peptide isolated and extracted from Bungarus venom, with broad-spectrum antimicrobial activity. However, due to the complex and high cost of obtaining and purifying the Bungarus cathelicin-BF, it cannot meet the requirements of large-scale production and wide application. Although recombinant DNA technology can increase the yield, the selection and optimization of the expression system still face challenges. Summary of the invention
[0004] The invention aims to accelerate yeast growth rate, improve antimicrobial peptide expression yield, shorten fermentation cycle, reduce production cost, and is suitable for large-scale fermentation production of cathelicin-BF, a method for producing cathelicin-BF by using recombinant Pichia pastoris.
[0005] The steps of the present invention are: a. Inoculate the cathelicin-BF strain of Bungarus cathelicin into YPD medium in a clean bench, culture at 30°C in a shaking incubator for 24 h at a speed of 250 rpm, and obtain a primary seed solution with a bacterial concentration of OD600 of 6-8; b. Then, 10×YNB, biotin and the first-level seed solution were inoculated into BMGY medium at 30°C and 250 rpm for 24 h to obtain the second-level seed solution; c. Prepare 2.5 L BMMY culture medium in a 5 L fermenter, sterilize at 121°C for 30 min, adjust the pH to 6.0 with 50% ammonia water, inoculate 10×YNB, biotin, glutamine, cholesterol and secondary seed solution into the fermenter, and when the dissolved oxygen changes dramatically and the wet weight of the bacteria is greater than 300 g / L, starve for 0.5-1 h, then use methanol to induce the expression of the Bungarus cathelicin-BF, and the induction ends after 96 h.
[0006] The BMMY culture medium of the present invention comprises: 20 g / L peptone, 10 g / L yeast extract, 13.4 g / L YNB, 0.4 mg / L biotin, 10 mL / L cholesterol and 1.8 g / L glutamine.
[0007] The 10×YNB, biotin, glutamine and cholesterol of the present invention cannot be sterilized at high temperature, and the aseptic filtration is performed in an ultra-clean workbench.
[0008] The culture temperature of the methanol induction stage of the present invention is 30°C, pH=6.0, rotation speed is 900 rpm, ventilation volume is 1.0-1.2vvm, and tank pressure is 0.08-0.12 MPa.
[0009] The methanol of the present invention is industrial methanol.
[0010] The optimized fermentation medium of the present invention contains a variety of growth regulators, which can effectively reduce the metabolic burden. The production method of the present invention adds biological regulators such as glutamine and cholesterol to the medium, which is helpful to regulate the metabolism of Pichia pastoris cells, promote the growth of yeast cells, and accelerate the expression of recombinant proteins. The product has high purity, which is conducive to simplifying the subsequent purification process, and can achieve large-scale production of the Bungarus cathelicin-BF antimicrobial peptide, thereby reducing production costs. The expression amount of the Bungarus cathelicin-BF antimicrobial peptide using the process reaches 675.7 mg / L. Compared with the protein yield before the BMMY medium is optimized, the fermentation level after the BMMY medium is optimized is increased by more than 17%. BRIEF DESCRIPTION OF THE DRAWINGS
[0011] Figure 1 A flow chart of producing the antimicrobial peptide cathelicin-BF of Bungarus bungarus using recombinant Pichia pastoris provided by the present invention; Figure 2 A bar graph showing the protein concentration of the fermentation supernatant of the cathelicin-BF antimicrobial peptide induced for 96 hours before and after the optimization of the BMMY medium provided by the present invention; Figure 3 The protein electrophoresis diagram of the fermentation supernatant of the cathelicin-BF antimicrobial peptide induced by Bungarus bungarus for 96 hours provided by the present invention, and the control is a blank control transferred into the pPIC9k empty vector; Figure 4The diagram of inhibition zone of the fermentation supernatant of the cathelicin-BF antimicrobial peptide of Bungarus bungeus at different induction times before optimization of the BMMY medium provided by the present invention against Escherichia coli DH5α; wherein 0, 24, 48, 72, and 96 represent the induction time in hours; the controls are the blank control into which the pPIC9k empty vector was transferred and the positive control of 100 μg / mL ampicillin; Figure 5 The diagram shows the inhibition zone of the fermentation supernatant of the cathelicin-BF antimicrobial peptide of Bungarus bungarus at different induction times before and after the optimization of the BMMY culture medium provided by the present invention against Escherichia coli DH5α. DETAILED DESCRIPTION
[0012] Fermentation process of the present invention: 1. Construction of recombinant expression plasmid pPIC9K-cathelicin-BF The gene fragment of the Bungarus fasciatus antimicrobial peptide with the sequence (KFFRKLKKSVKKRAKEFFKKPRVIGVSIPF) was connected to the secretory expression vector pPIC9K, and the obtained recombinant vector was transformed into the host Pichia pastoris cell GS115 to construct a Pichia pastoris strain that efficiently expresses the Bungarus fasciatus antimicrobial peptide.
[0013] The Pichia pastoris strain was a GS115 competent cell purchased from Wuhan Puint Bioengineering Co., Ltd. After we constructed the recombinant expression plasmid pPIC9K-cathelicin-BF, we transformed it according to the instructions of Puint's GS115 competent cells to obtain a Pichia pastoris strain that efficiently expressed the Bungarus antimicrobial peptide.
[0014] The reference patent of the present invention (a method for efficiently preparing the antimicrobial peptide Cath-BF30 of Bungarus bungeus) constructs a Pichia pastoris strain that efficiently expresses the antimicrobial peptide of Bungarus bungeus, and the specific steps are: synthesizing the cathelicin-BF gene of the antimicrobial peptide of Bungarus bungeus, and cloning it into the pPIC9K vector to obtain the recombinant expression plasmid pPIC9K-cathelicin-BF; transforming the recombinant expression plasmid pPIC9K-cathelicin-BF into the competent cells of Pichia pastoris according to the competent instructions of Pichia pastoris GS115, and obtaining the Pichia pastoris strain that efficiently expresses the antimicrobial peptide of Bungarus bungeus; the strain is fermented in an optimized culture medium, and the fermentation supernatant can significantly inhibit the growth of Escherichia coli.
[0015] 2. Inducible expression of recombinant pPIC9K-cathelicin-BF 1. Culture media and solutions used in the fermentation process 1) YPD medium: Peptone 20 g / L, yeast extract 10 g / L, glucose 20 g / L; 2) BMGY medium: Peptone 20 g / L, yeast extract 10 g / L, YNB13.4 g / L, glycerol 10 g / L, biotin 0.4 mg / L; 3) BMMY medium: Peptone 20 g / L, yeast extract 10 g / L, YNB 13.4 g / L, biotin 0.4 mg / L; 4) Optimized BMMY medium: Peptone 20 g / L, yeast extract 10 g / L, YNB 13.4 g / L, biotin 0.4 mg / L, cholesterol 10 mL / L, glutamine 1.8 g / L.
[0016] 2. High-density fermentation culture of pPIC9K-cathelicin-BF (method for fermentation production of Bungarus antimicrobial peptide pPIC9K-cathelicin-BF): 1) Cultivation of primary seed solution: prepare 25 mL YPD medium in a 250 mL shake flask, wrap the bottle mouth with sealing film, sterilize at 115℃ for 20 minutes, and cool to room temperature; inoculate the constructed pPIC9K-cathelicin-BF recombinant Pichia pastoris strain at a 1% inoculum amount in a sterilized 100 mL Erlenmeyer flask containing 25 mL YPD medium in an ultra-clean workbench. The culture conditions are: rotation speed 250 rpm, temperature 30℃, and culture for about 24 h until the bacterial concentration reaches OD600=6-8.
[0017] 2) Cultivation of secondary seed solution: prepare 250 mL of BMGY medium, divide into five 500 mL shake flasks, wrap the bottle mouth with sealing film, sterilize at 121℃ for 20 min, and cool to room temperature; inoculate the primary seed solution into a 500 mL Erlenmeyer flask containing 50 mL of BMGY medium in an ultra-clean workbench at a 5% inoculation rate, and culture conditions are: rotation speed 250 rpm, temperature 30℃, and culture for about 24 h.
[0018] The reason for culturing seed liquid in the first two steps is that the preserved bacterial strains are insufficient and the amount of bacteria required for fermentation is too large. Cultivating seed liquid can reproduce a large number of bacteria with strong vitality.
[0019] 3) High-density fermentation in 5 L fermenter: ① High-density fermentation in a fermenter with 5 L optimized BMMY medium: The difference is that in this step, the formula of BMMY medium in the fermenter is: Peptone 20 g / L, yeast extract 10 g / L, YNB 13.4 g / L, biotin 0.4 mg / L, cholesterol 10 mL / L, and glutamine 1.8 g / L.
[0020] 2.5 L of optimized BMMY culture medium was prepared in a 5L fermenter and sterilized at 121°C for 30 minutes. At the same time, steam was used to sterilize the feed tank, pipelines and air filters, and cooled to room temperature. 50% ammonia water was used to adjust the pH to 6.0, and 10×YNB, biotin, glutamine, cholesterol and secondary seed liquid were inoculated in a 5L fermenter for culture. The tank temperature was controlled at 30°C, and the pH was adjusted and controlled to 6.0 with ammonia water. The ventilation volume was 1.0-1.2 vvm, the tank pressure was 0.08-0.12 MPa, the rotation speed was 900 rpm, and the dissolved oxygen was controlled to be >30%. When the dissolved oxygen recovered rapidly, the cells were starved for 0.5-1 h and then methanol was added to induce the expression of cathelicin-BF, an antimicrobial peptide of Bungarus bungeus. During the methanol induction stage, the tank temperature was controlled at 30 °C, pH = 6.0, the rotation speed was 900 rpm, the ventilation volume was 1.0-1.2 vvm, and the tank pressure was 0.04-0.05 MPa. The methanol flow acceleration was controlled by dissolved oxygen feedback to control the dissolved oxygen > 30%, and the fermentation ended after 96 h of induction.
[0021] ② (Comparative experiment) High-density fermentation of 5 L BMMY medium before optimization in a fermenter: Prepare 2.5 L BMMY culture medium in a 5L fermenter, sterilize at 121°C for 30 minutes, and use steam to sterilize the feed tank, each pipeline and air filter, and cool to room temperature. Use 50% ammonia water to adjust the pH to 6.0, inoculate 10×YNB, biotin, glutamine, cholesterol and secondary seed liquid in a 5L fermenter for culture, control the tank temperature at 30°C, adjust and control the pH to 6.0 with ammonia water, the ventilation volume is 1.0-1.2vvm, the tank pressure is 0.08-0.12 MPa, the rotation speed is 900 rpm, and the dissolved oxygen is controlled to be >30%. When the dissolved oxygen recovered rapidly, the cells were starved for 0.5-1 h and then methanol was added to induce the expression of the Bungarus cathelicin-BF antimicrobial peptide. During the methanol induction stage, the tank temperature was controlled at 30 °C, pH = 6.0, rotation speed was 900 rpm, ventilation volume was 1.0-1.2 vvm, tank pressure was 0.04-0.05 MPa, and the methanol flow acceleration was controlled by dissolved oxygen feedback to control the dissolved oxygen > 30%. The fermentation ended after 96 h of induction.
[0022] After 96 h of induction, the fermentation was completed and the tank was released. The fermentation supernatant was collected every 24 h for the antibacterial activity test of the Bungarus cathelicin-BF antimicrobial peptide and protein concentration test.
[0023] Determination of cathelicin-BF protein concentration of Bungarus bungarus antimicrobial peptide The total protein concentration of the fermentation supernatant at different induction times is shown in Tables 1 and 2. Using the BCA method kit, the absorbance of the BSA standard was measured using a spectrophotometer according to the steps required by the instructions, and a standard curve was drawn. The concentration of the sample protein was calculated based on the standard curve and the absorbance value and dilution multiple of the sample.
[0024] Table 1 Total protein concentration of fermentation supernatant at different induction times before BMMY medium optimization
[0025] Table 2 Total protein concentration of fermentation supernatant at different induction times after optimization of BMMY medium
[0026] As can be seen from Tables 1 and 2, the protein concentration gradually increased with the increase of induction time. At 96 h of induction, the protein concentration before BMMY medium optimization reached 576.2 mg / L, and the protein concentration after BMMY medium optimization reached 675.7 mg / L.
[0027] Figure 2 This is a bar graph showing the protein concentration of the supernatant of the fermentation of cathelicin-BF, an antimicrobial peptide of Bungarus bungeus, before and after 96 h of induction in BMMY medium optimization. Figure 2 It can be seen that the protein concentration of the fermentation supernatant of cathelicin-BF, an antimicrobial peptide of the Bungarus aegypti, increased significantly after the optimization of the BMMY medium, which was induced for 96 h. This fully demonstrates that the addition of biological regulators such as glutamine and cholesterol to the culture medium can help promote the growth of Pichia pastoris cells and accelerate the expression of cathelicin-BF, an antimicrobial peptide of the Bungarus aegypti.
[0028] Figure 3 The protein electrophoresis diagram of the supernatant of the fermentation of cathelicin-BF, an antimicrobial peptide of Bungarus bungarus, for 96 h. Figure 3 It can be seen that at 96 h of induction, the cathelicin-BF band of the Bungarus cathelicin was obvious, the purity of the bungarus cathelicin-BF in the fermentation supernatant was high, and only a small amount of impurity protein was present, which can simplify the separation and purification process of the bungarus cathelicin-BF protein and reduce production costs.
[0029] Determination of antibacterial activity of cathelicin-BF from Bungarus bungarus ① Use 25 mL LB liquid medium to culture Escherichia coli DH5α. After overnight culture at 37℃ 220 rpm, transfer to 25 mL LB liquid medium and culture under the same conditions for 1.5 h-2h. When the OD600 value is between 0.4-0.6, take 100 μL of bacterial liquid and evenly spread it on the medium and punch holes in the medium with an Oxford cup. Then add 100 μL of the fermentation supernatant of the Bungarus cathelicin-BF antimicrobial peptide with different induction times to each well. At the same time, use pPIC9k empty vector as blank control and 100 μg / mL ampicillin as positive control. After overnight culture at 37℃, measure the size of the transparent circle.
[0030] Depend on Figure 4 It can be seen that the induced expressed Bungarus cathelicin-BF antimicrobial peptide has obvious antibacterial activity against Escherichia coli DH5α.
[0031] ② (Comparative experiment) Escherichia coli DH5α was cultured in 25 mL LB liquid medium. After overnight culture at 37℃ and 220 rpm, it was transferred to 25 mL LB liquid medium and cultured under the same conditions for 1.5 h-2 h. When the OD600 value was between 0.4-0.6, 100 μL of the bacterial liquid was evenly spread on the medium and holes were made on the medium with an Oxford cup. Then, 100 μL of the fermentation supernatant of the Bungarus cathelicin-BF antimicrobial peptide before and after 96 h of induction with Bombmy medium optimization was added to each well. At the same time, the pPIC9k empty vector was used as a blank control. After overnight culture at 37℃, the size of the transparent zone was measured.
[0032] Figure 5 The inhibition zone diagram of the fermentation supernatant of cathelicin-BF, an antimicrobial peptide from Bungarus spp., against Escherichia coli DH5α before and after 96 hours of induction for BMMY medium optimization. Figure 5 It can be seen that the cathelicin-BF antimicrobial peptide expressed after culture medium optimization has stronger antibacterial activity against Escherichia coli DH5α.
Claims
1. A method for producing a Bungarus antimicrobial peptide using recombinant Pichia pastoris, characterized in that: The steps are: a. Inoculate the cathelicin-BF strain of Bungarus cathelicin into YPD medium in a clean bench, culture at 30°C in a shaking incubator for 24 h at a speed of 250 rpm, and obtain a primary seed solution with a bacterial concentration of OD600 of 6-8; b. Then, 10×YNB, biotin and the first-level seed solution were inoculated into BMGY medium at 30°C and 250 rpm for 24 h to obtain the second-level seed solution; c. Prepare 2.5 L BMMY culture medium in a 5 L fermenter, sterilize at 121°C for 30 min, adjust the pH to 6.0 with 50% ammonia water, inoculate 10×YNB, biotin, glutamine, cholesterol and secondary seed solution into the fermenter, and when the dissolved oxygen changes dramatically and the wet weight of the bacteria is greater than 300 g / L, starve for 0.5-1 h, then use methanol to induce the expression of the Bungarus cathelicin-BF, and the induction ends after 96 h.
2. The method for producing a Bungarus antimicrobial peptide using recombinant Pichia pastoris according to claim 1, characterized in that: BMMY medium: Peptone 20 g / L, yeast extract 10 g / L, YNB 13.4 g / L, biotin 0.4 mg / L, cholesterol 10 mL / L, glutamine 1.8 g / L.
3. The method for producing a Bungarus antimicrobial peptide using recombinant Pichia pastoris according to claim 1, characterized in that: 10×YNB, biotin, glutamine and cholesterol cannot be sterilized at high temperature, and sterile filtration is carried out in an ultra-clean workbench.
4. The method for producing a Bungarus antimicrobial peptide using recombinant Pichia pastoris according to claim 1, characterized in that: The culture temperature during the methanol induction phase was 30°C, pH = 6.0, rotation speed 900 rpm, ventilation volume 1.0-1.2 vvm, and tank pressure 0.08-0.12 MPa.
5. The method for producing a Bungarus antimicrobial peptide using recombinant Pichia pastoris according to claim 1, characterized in that: The methanol is industrial methanol.
Citation Information
Patent Citations
Antibacterial peptide preparation method and specific strain thereof
CN101892277A
Induction method for improving yield of king cobra antibacterial peptide expressed by pichia pastoris
CN115820529A
Antibacterial peptide Cathlicidin-BF and expression and application thereof in pichia pastoris
CN115947814A
Recombinant yeast strain for expressing humanlactoferricin and process for preparation recombinanthuman lactoferricin using the same
KR1020000029180A
Fermentation process with pichia yeast expressing recombinant protein
US20190309339A1
